Abiopharma

BWMN Investors Have Opportunity to Join Bowman Consulting Group Ltd. Fraud Investigation with SBS Law

Clinical trial NCT07728942: start date: 2026-07-01 → 2026-08-04.

Clinical trial NCT06183931 updates: 1. completion date: 2027-10-05 → 2028-04-05 2. primary completion date: 2027-06-07 → 2027-12-06

Clinical trial NCT05813704 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-05-01 → 2024-08-19 3. primary completion date: 2025-04-01 → 2024-07-19 4. enrollment: 156 → 159 participants 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: LanZhou University 7. collaborators removed: Lanzhou University First Hospital

Clinical trial NCT07086755 updates: 1. completion date: 2026-07-01 → 2031-05-31 2. primary completion date: 2026-07-01 → 2031-05-31 3. collaborators added: Akebia Therapeutics 4. collaborators removed: Akebia Therapeutics Inc.

Clinical trial NCT05531656 updates: 1. completion date: 2027-04-01 → 2027-05-31 2. primary completion date: 2027-04-01 → 2027-05-31

Clinical trial NCT07251491: start date: 2026-05-01 → 2026-08-06.

Clinical trial NCT06926868: enrollment: 500 → 600 participants.

Clinical trial NCT06240754 updates: 1. completion date: 2029-02-28 → 2029-06-30 2. primary completion date: 2028-01-31 → 2028-05-31

Clinical trial NCT07473973 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-11-07 → 2026-10-14 3. primary completion date: 2028-09-11 → 2026-10-14